Zentalis grants stock options for 62,000 shares to three new hires under inducement plan

ZNTL•2026-10-01

Zentalis Pharmaceuticals granted options covering 62,000 shares to three new hires on Oct. 1, 2026, under its 2022 Employment Inducement Incentive Award Plan.

Zentalis grants stock options for 62,000 shares to three new hires under inducement plan

1. Option grant details

Related News

First Solar files patent infringement lawsuit against JA Solar and American Panel Solutions

Oceaneering wins U.S. Navy Dry Deck Shelter services contract worth up to $154 million

Industrial Logistics Properties Trust updates financial calendar with third-quarter 2026 results release, conference call

Ameresco files initial beneficial ownership statement for interim PFO Julie A. Bradshaw

RTX Raytheon wins contract worth up to $24.4 billion for SM-6 interceptors